Given increasing evidence concerning a role of LPS and TLR4 in PD (Gorecki et al., 2019, 2020; Perez-Pardo et al., 2019), further targeted studies investigating TLR4 and CD14 polymorphisms in larger cohorts are warranted. This evidence concerns the gene TLR4 and Parkinson disease.